Guiyang Xintian Pharmaceutical (002873.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved revenue...
Zhītōng Financial APP news, Guiyang Xintian Pharmaceutical (002873.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved revenue of 0.661 billion yuan, a 14.80% decrease year-on-year. The net income attributable to the shareholders of the listed company was 60.9998 million yuan, a 30.45% decrease year-on-year. The net income attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 42.2651 million yuan, a 49.20% decrease year-on-year.